Page last updated: 2024-09-05

erlotinib hydrochloride and Anemia, Macrocytic

erlotinib hydrochloride has been researched along with Anemia, Macrocytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Greve, J; Decoster, L; Fontaine, C; Schallier, D; Trullemans, F	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Anemia, Macrocytic

Article	Year
Tyrosine kinase inhibitor-induced macrocytosis. Anticancer research, 2009, Volume: 29, Issue:12 Topics: Anemia, Macrocytic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzenesulfonates; Erlotinib Hydrochloride; Humans; Imatinib Mesylate; Indoles; Neoplasm Staging; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Retrospective Studies; Sorafenib; Sunitinib; Survival Rate	2009

Article

Year

Tyrosine kinase inhibitor-induced macrocytosis.

Anticancer research, 2009, Volume: 29, Issue:12

Topics: Anemia, Macrocytic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzenesulfonates; Erlotinib Hydrochloride; Humans; Imatinib Mesylate; Indoles; Neoplasm Staging; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Retrospective Studies; Sorafenib; Sunitinib; Survival Rate

2009